Indraprastha Apollo Hospitals in New Delhi, India, has become the first hospital in the country to install bioMerieux’s MALDI-TOF-VITEK MS system, which is used to reduce the delivery time of clinical test results for identifying microbial infections.
The hospital will leverage the automated microbial identification system that is based on Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) for the rapid identification of disease-causing micro-organisms, such as bacteria and fungi.
Apollo Hospitals Group senior consultant (microbiology) and medical services additional director Dr. Raman Sardana said the speed of diagnostic laboratory results has an impact on reducing the increasing antimicrobial resistance.
"The rapid identification of micro-organisms has been shown to help guide patient treatment and improve clinical outcomes," Sardana added.
"Waiting several days for a definitive identification of the pathogen provides an obstacle to the clinician seeking to target therapy with the most effective treatment.
"This is where technologies such as MALDI-TOF-VITEK MS are helpful with their accuracy and specificity."
MALDI-TOF-VITEK MS enables the rapid identification of the type of infection or infections, thereby allowing healthcare providers to offer specific targeted therapies.
The mass spectrometry technique aids in screening a huge number of molecules at once and determining the identity of microbes by stimulating them with a laser and analysing their protein pattern by analysing their individual mass-to-charge ratio.
Such molecular signatures can be used in bacterial and fungal identification from isolated colonies.